FANS for the CURE is excited about our first important step in supporting prostate cancer research by becoming an Advocacy Partner for the Metastatic Prostate Cancer Project (MPCP) — a nationwide genomic research initiative designed for men with advanced or metastatic prostate cancer. This cutting-edge project, which is being conducted at the Broad Institute of MIT and Harvard in collaboration with Dana-Farber Cancer Institute, takes a new approach to genomic research by working directly with men with advanced and metastatic prostate cancer to accelerate important discoveries.
The project will create the most comprehensive prostate cancer database that will be shared with the entire research community and enable scientists to look at patient-provided, de-identified data, tumor samples, clinical information and more — allowing for more exhaustive research into prostate cancer and its treatment.
Leading this exciting new initiative is Dr. Eli Van Allen, a clinical computational oncologist and prostate cancer researcher at Dana-Farber Cancer Institute and Associate Member of the Broad Institute. Listen to Dr. Eli Van Allen’s play-by-play on the Metastatic Prostate Cancer Project. FANS for the CURE Board, Chairman Steve Garvey and Dr. Van Allen talk baseball and how the Metastatic Prostate Cancer Project will bring new insights to fuel a new era of prostate cancer research.
Read more about this exciting new initiative.
With your support FANS for the CURE will step up our promotion of research in the greatest areas of need.Donate Now